Latest News
Your Resource for the Latest News!
We seek to keep you updated on the latest Lupus News, Research, Press Releases and Clinical Trials.
COVID-19 TRIAL NOW ENROLLING PARTICIPANTS
The study is open to adults who
- Tested positive for COVID with symptoms starting within the last 5 days and
- Aged 18–49 years with chronic condition(s) or 50+ years regardless of health status
Eligible participants will
- Take a COVID medication approved by Health Canada or follow public health advice on COVID
- Complete an online diary from Day 1 to 14
- Complete a survey on Day 21, 28 and 90 and Week 36
- Receive $30 for each follow-up
Participation is voluntary.
Call for Abstracts
Have you heard? The 2023 Lupus Ontario Annual Symposium Call for Abstracts has launched!
The theme this year is Caring for All. Known as the disease of a thousand faces, we will highlight the disparities in diagnosing and treating lupus including:
- Ethnicity and issues of race in lupus diagnosis
- Caring for lupus patients in northern and rural Ontario
- Growing-up with lupus: Transition from pediatric to adult care
- Improving Access and Enhancing Care: Physician Education and Best Practices
- And more!
Lupus Awareness Month
May is Lupus Awareness Month, with May 10th being declared Lupus Awareness Day in Ontario. Take a look at what is being illuminated to spread awareness in Ontario.
Find our Media Kits with resources to help spread awareness.
SUMMER 2023 - STUDENT JOB POSTING
We are looking for a Marketing Assistant for summer under the Canada Summer Jobs Program.
Walk For Lupus Ontario Media Kit -
Social Media Posts, Captions, Video and Articles for you to share!
12-year-old sisters start business supporting Pediatric Lupus Clinic
In April and May proceeds will support the Pediatric Lupus Clinic at SickKids Hospital
EVUSHELD™ receives Health Canada approval
EVUSHELD™ RECEIVES HEALTH CANADA APPROVAL FOR PRE-EXPOSURE PROPHYLAXIS (PREVENTION) OF COVID-19 IN IMMUNE-COMPROMISED INDIVIDUALS
Tribute For Dr. Urowitz
Honouring Dr. Dr.Murray B Urowitz on his retirement! Thank you for all you have done for the Lupus Community.
SHINGRIX approved in Canada for adults at increased risk of shingles
GSK PRESS RELEASE – SHINGRIX approved in Canada for adults at increased risk of shingles due to immunodeficiency or immunosuppression
GOC signs new COVID-19 antibody therapy agreement
PRESS RELEASE – from Public Services and Procurement Canada.
